{"id":44239,"date":"2022-10-03T07:26:30","date_gmt":"2022-10-03T07:26:30","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=44239"},"modified":"2024-04-07T11:26:29","modified_gmt":"2024-04-07T11:26:29","slug":"platinum-study-tecovirimat-treatment-for-monkeypox-in-the-uk","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/44239","title":{"rendered":"Tecovirimat treatment for monkeypox in the UK: importance of the PLATINUM study"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead2articletitle\"><strong>Simon Collins, HIV i-Base<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\"><a href=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2022\/06\/typical-MPV-rash-on-hand-2-colour1.png\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-43297 alignright\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2022\/06\/typical-MPV-rash-on-hand-2-colour1-300x236.png\" alt=\"\" width=\"181\" height=\"144\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2022\/06\/typical-MPV-rash-on-hand-2-colour1-1024x807.png 1024w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2022\/06\/typical-MPV-rash-on-hand-2-colour1-768x605.png 768w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2022\/06\/typical-MPV-rash-on-hand-2-colour1.png 1098w\" sizes=\"auto, (max-width: 181px) 100vw, 181px\" \/><\/a>The PLATINUM study is currently running in the UK for anyone diagnosed with mild-moderate monkeypox (MPX) and who is currently not being seen as an inpatient. [1]<\/span><\/strong><\/p>\n<\/div>\n<div>\n<ul>\n<li class=\"HTBBODYtext\"><span lang=\"EN-US\">Enrolment only requires a standard email from a doctor to confirm the MPX diagnosis.<\/span><\/li>\n<\/ul>\n<\/div>\n<div>\n<ul>\n<li class=\"HTBBODYtext\"><span lang=\"EN-US\">No clinic visits are required and study meds are posted and responses are collected virtually.<\/span><\/li>\n<\/ul>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Tecovirimat is the most promising antiviral against MPX and access outside this study is generally limited to severe cases that require hospitalisation. <\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Information about tecovirimat was included in the previous issue of HTB, also highlighting this study.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">The reduced cases in the UK make enrolment into this study extremely important, in addition to offering potentially better treatment than the current standard of care.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBreferences\"><span lang=\"EN-US\">References<\/span><\/p>\n<\/div>\n<div>\n<ol>\n<li class=\"HTBreferences\"><span lang=\"EN-US\">The PLATINUM study website.<br \/>\n<\/span><a href=\"https:\/\/www.platinumtrial.ox.ac.uk\">https:\/\/www.platinumtrial.ox.ac.uk<\/a><\/li>\n<li class=\"HTBreferences\">Tecovirimat for treating mild monkeypox: new studies open in the UK and US<br \/>\n<a href=\"https:\/\/i-base.info\/htb\/43758\">https:\/\/i-base.info\/htb\/43758<\/a><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base The PLATINUM study is currently running in the UK for anyone diagnosed with mild-moderate monkeypox (MPX) and who is currently not being seen as an inpatient. [1] Enrolment only requires a standard email from a doctor &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[323],"tags":[],"class_list":["post-44239","post","type-post","status-publish","format-standard","hentry","category-mpox"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/44239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=44239"}],"version-history":[{"count":7,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/44239\/revisions"}],"predecessor-version":[{"id":47605,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/44239\/revisions\/47605"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=44239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=44239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=44239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}